Top compounds associated with response to PCCB


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0091 0.8
mRNA azacitidine CTRPv2 pan-cancer AAC -0.0096 0.8
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.0087 0.8
mRNA AZD8055 GDSC1000 pan-cancer AAC -0.0082 0.8
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.0089 0.8
mRNA Bicalutamide FIMM pan-cancer AAC 0.04 0.8
mRNA AS601245 GDSC1000 pan-cancer AAC 0.0083 0.8
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0085 0.8
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.0089 0.8
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC 0.0071 0.8
Download CSV